Agios Pharmaceuticals Inc (AGIO)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: AGIO Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-04-10 2024-04-10 PS Planned sale

FOUSE JACQUALYN A

Non-Executive Director
7,791 -5.4%
27.55
214,642 USD 		7,791 -5.4% 27.55 214,642 USD
2024-03-11 2024-03-07 S Sale

Foster-Cheek Kaye I

Non-Executive Director
1,285 -18.9%
31.62
40,632 USD 		1,285 -18.9% 31.62 40,632 USD
2024-03-07 2024-03-06 S Sale

Foster-Cheek Kaye I

Non-Executive Director
4,415 -39.3%
31.99
141,236 USD 		4,415 -39.3% 31.99 141,236 USD
2024-03-07 2024-03-05 S Sale

Foster-Cheek Kaye I

Non-Executive Director
300 -2.6%
32.21
9,663 USD 		300 -2.6% 32.21 9,663 USD
2024-03-07 2024-03-05 S Sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
1,913 -39.9%
31.75
60,738 USD 		1,913 -39.9% 31.75 60,738 USD
2024-03-05 2024-03-05 PS Planned sale

Jones Cecilia

Chief Financial Officer

Officer
672 -4.3%
32.57
21,887 USD 		672 -4.3% 32.57 21,887 USD
2024-03-05 2024-03-05 PS Planned sale

Goff Brian

Chief Executive Officer

Executive Director
4,156 -7.2%
32.57
135,361 USD 		4,156 -7.2% 32.57 135,361 USD
2024-03-05 2024-03-05 PS Planned sale

Gheuens Sarah

Chief Medical Officer

Officer
1,349 -3.3%
32.57
43,937 USD 		1,349 -3.3% 32.57 43,937 USD
2024-03-05 2024-03-05 PS Planned sale

Gheuens Sarah

Chief Medical Officer

Officer
1,293 -3.4%
32.57
42,113 USD 		1,293 -3.4% 32.57 42,113 USD
2024-03-05 2024-03-05 PS Planned sale

Burns James William

Chief Legal Officer

Officer
1,349 -3.5%
32.57
43,937 USD 		1,349 -3.5% 32.57 43,937 USD
2024-03-05 2024-03-05 PS Planned sale

Burns James William

Chief Legal Officer

Officer
1,293 -3.6%
32.57
42,113 USD 		1,293 -3.6% 32.57 42,113 USD
2024-03-05 2024-03-05 PS Planned sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
919 -16.1%
32.57
29,932 USD 		919 -16.1% 32.57 29,932 USD
2024-03-05 2024-03-05 PS Planned sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
295 -8.1%
32.57
9,608 USD 		295 -8.1% 32.57 9,608 USD
2024-02-29 2024-02-27 S Sale

Schenkein David P

Non-Executive Director
57,471 -31.9%
34.89
2,005,163 USD 		57,471 -31.9% 34.89 2,005,163 USD
2024-02-29 2024-02-27 S Sale

Schenkein David P

Non-Executive Director
11,858 -8.8%
33.60
398,429 USD 		11,858 -8.8% 33.60 398,429 USD
2024-02-27 2024-02-26 S Sale

Schenkein David P

Non-Executive Director
20,411 -14.2%
33.19
677,441 USD 		20,411 -14.2% 33.19 677,441 USD
2024-02-27 2024-02-23 S Sale

Schenkein David P

Non-Executive Director
47,731 -28.0%
33.05
1,577,510 USD 		47,731 -28.0% 33.05 1,577,510 USD
2024-02-22 2024-02-20 S Sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
504 -15.5%
26.63
13,422 USD 		504 -15.5% 26.63 13,422 USD
2024-02-14 2024-02-14 PS Planned sale

Burns James William

Chief Legal Officer

Officer
545 -1.7%
25.14
13,701 USD 		545 -1.7% 25.14 13,701 USD
2024-02-14 2024-02-14 PS Planned sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
273 -7.8%
25.14
6,863 USD 		273 -7.8% 25.14 6,863 USD
2024-02-14 2024-02-14 PS Planned sale

Gheuens Sarah

Chief Medical Officer

Officer
642 -1.9%
25.14
16,140 USD 		642 -1.9% 25.14 16,140 USD
2024-01-24 2024-01-24 PS Planned sale

Goff Brian

Chief Executive Officer

Executive Director
7,635 -13.4%
21.64
165,221 USD 		7,635 -13.4% 21.64 165,221 USD
2024-01-24 2024-01-24 PS Planned sale

Jones Cecilia

Chief Financial Officer

Officer
1,886 -12.6%
21.64
40,813 USD 		1,886 -12.6% 21.64 40,813 USD
2024-01-24 2024-01-24 PS Planned sale

FOUSE JACQUALYN A

Non-Executive Director
10,722 -7.7%
21.64
232,024 USD 		10,722 -7.7% 21.64 232,024 USD
2024-01-24 2024-01-24 PS Planned sale

Gheuens Sarah

Chief Medical Officer

Officer
1,708 -5.1%
21.64
36,961 USD 		1,708 -5.1% 21.64 36,961 USD
2024-01-24 2024-01-24 PS Planned sale

Burns James William

Chief Legal Officer

Officer
1,708 -5.3%
21.64
36,961 USD 		1,708 -5.3% 21.64 36,961 USD
2024-01-24 2024-01-24 PS Planned sale

Milanova Tsveta

Chief Commercial Officer

Officer
1,618 -10.9%
21.64
35,014 USD 		1,618 -10.9% 21.64 35,014 USD
2024-01-09 2024-01-09 PS Planned sale

FOUSE JACQUALYN A

Non-Executive Director
8,391 -6.7%
22.99
192,909 USD 		8,391 -6.7% 22.99 192,909 USD
2024-01-09 2024-01-09 PS Planned sale

Goff Brian

Chief Executive Officer

Executive Director
12,066 -23.2%
22.99
277,397 USD 		12,066 -23.2% 22.99 277,397 USD
2024-01-09 2024-01-09 PS Planned sale

Burns James William

Chief Legal Officer

Officer
1,163 -4.2%
22.99
26,737 USD 		1,163 -4.2% 22.99 26,737 USD
2024-01-09 2024-01-09 PS Planned sale

Gheuens Sarah

Chief Medical Officer

Officer
1,789 -6.0%
22.99
41,129 USD 		1,789 -6.0% 22.99 41,129 USD
2024-01-05 2024-01-05 PS Planned sale

Milanova Tsveta

Chief Commercial Officer

Officer
2,902 -23.6%
22.32
64,773 USD 		2,902 -23.6% 22.32 64,773 USD
2023-09-28 2023-09-28 PS Planned sale

Jones Cecilia

Chief Financial Officer

Officer
2,179 -18.5%
24.79
54,017 USD 		2,179 -18.5% 24.79 54,017 USD
2023-08-21 2023-08-17 S Sale

Burns James William

Chief Legal Officer

Officer
6,395 -21.1%
26.28
168,061 USD 		6,395 -21.1% 26.28 168,061 USD
2023-08-11 2023-08-09 S Sale

Foster-Cheek Kaye I

Non-Executive Director
25,000 -68.4%
25.96
648,888 USD 		25,000 -68.4% 25.96 648,888 USD
2023-08-10 2023-08-08 S Sale

Goff Brian

Chief Executive Officer

Executive Director
10,178 -27.7%
25.48
259,335 USD 		10,178 -27.7% 25.48 259,335 USD
2023-08-09 2023-08-07 S Sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
2,918 -51.6%
25.39
74,096 USD 		2,918 -51.6% 25.39 74,096 USD
2023-08-02 2023-08-01 S Sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
1,232 -17.9%
26.26
32,352 USD 		1,232 -17.9% 26.26 32,352 USD
2023-04-05 2023-04-03 PS Planned sale

Schenkein David P

Non-Executive Director
16,363 -12.2%
22.85
373,895 USD 		16,363 -12.2% 22.85 373,895 USD
2023-03-29 2023-03-27 PS Planned sale

Schenkein David P

Non-Executive Director
20,000 -14.5%
22.15
443,000 USD 		20,000 -14.5% 22.15 443,000 USD
2023-03-15 2023-03-13 PS Planned sale

Schenkein David P

Non-Executive Director
1,667 -1.4%
22.72
37,874 USD 		1,667 -1.4% 22.72 37,874 USD
2023-03-15 2023-03-13 PS Planned sale

Schenkein David P

Non-Executive Director
18,333 -13.3%
22.47
411,943 USD 		18,333 -13.3% 22.47 411,943 USD
2023-03-07 2023-03-03 PS Planned sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
504 -15.5%
24.29
12,242 USD 		504 -15.5% 24.29 12,242 USD
2023-03-01 2023-02-27 PS Planned sale

Schenkein David P

Non-Executive Director
20,000 -14.5%
25.37
507,400 USD 		20,000 -14.5% 25.37 507,400 USD
2023-02-21 2023-02-16 PS Planned sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
233 -8.0%
27.21
6,340 USD 		233 -8.0% 27.21 6,340 USD
2023-02-16 2023-02-14 PS Planned sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
504 -14.8%
28.59
14,409 USD 		504 -14.8% 28.59 14,409 USD
2023-02-15 2023-02-13 PS Planned sale

Schenkein David P

Non-Executive Director
20,000 -14.5%
28.62
572,400 USD 		20,000 -14.5% 28.62 572,400 USD
2023-02-01 2023-01-30 PS Planned sale

Schenkein David P

Non-Executive Director
3,300 -2.7%
29.88
98,604 USD 		3,300 -2.7% 29.88 98,604 USD
2023-02-01 2023-01-30 PS Planned sale

Schenkein David P

Non-Executive Director
16,700 -12.1%
29.22
487,974 USD 		16,700 -12.1% 29.22 487,974 USD
2023-01-19 2023-01-17 PS Planned sale

Schenkein David P

Non-Executive Director
1,034 -0.9%
29.49
30,493 USD 		1,034 -0.9% 29.49 30,493 USD
2023-01-19 2023-01-17 PS Planned sale

Schenkein David P

Non-Executive Director
18,966 -13.8%
28.82
546,600 USD 		18,966 -13.8% 28.82 546,600 USD
2022-03-01 2022-02-25 PS Planned sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
108 -4.1%
30.00
3,240 USD 		108 -4.1% 30.00 3,240 USD
2022-02-18 2022-02-16 PS Planned sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
233 -8.4%
30.81
7,179 USD 		233 -8.4% 30.81 7,179 USD
2022-02-16 2022-02-14 PS Planned sale

Washburn Theodore James Jr.

Principal Accounting Officer

Officer
504 -15.3%
31.25
15,750 USD 		504 -15.3% 31.25 15,750 USD
2021-06-22 2021-06-18 PS Planned sale

Bowden Christopher

Chief Medical Officer

Officer
48,493 -75.8%
60.11
2,914,851 USD 		48,493 -75.8% 60.11 2,914,851 USD
2021-06-11 2021-06-10 PS Planned sale

Bowden Christopher

Chief Medical Officer

Officer
20,853 -57.4%
60.06
1,252,437 USD 		20,853 -57.4% 60.06 1,252,437 USD
2021-06-11 2021-06-09 PS Planned sale

Bowden Christopher

Chief Medical Officer

Officer
7,149 -31.6%
60.16
430,117 USD 		7,149 -31.6% 60.16 430,117 USD
2021-06-09 2021-06-08 PS Planned sale

Bowden Christopher

Chief Medical Officer

Officer
6,675 -30.1%
60.07
400,939 USD 		6,675 -30.1% 60.07 400,939 USD
2021-06-09 2021-06-07 PS Planned sale

Bowden Christopher

Chief Medical Officer

Officer
4,268 -21.6%
60.04
256,232 USD 		4,268 -21.6% 60.04 256,232 USD
2021-04-16 2021-04-15 PS Planned sale

Alenson Carman

Principal Accounting Officer

Officer
991 -47.0%
54.00
53,514 USD 		991 -47.0% 54.00 53,514 USD
2021-03-16 2021-03-05 S Sale

Miles Darrin

Chief Commercial Officer

Officer
500 -4.5%
48.58
24,290 USD 		500 -4.5% 48.58 24,290 USD
2021-03-16 2021-03-01 PS Planned sale

Miles Darrin

Chief Commercial Officer

Officer
2,200 -16.5%
47.99
105,578 USD 		2,200 -16.5% 47.99 105,578 USD
2020-09-04 2020-09-02 PS Planned sale

Alenson Carman

Principal Accounting Officer

Officer
250 -57.6%
39.93
9,983 USD 		250 -57.6% 39.93 9,983 USD
2020-05-21 2020-05-20 PS Planned sale

Bowden Christopher

Chief Medical Officer

Officer
3,583 -30.1%
50.01
179,200 USD 		3,583 -30.1% 50.01 179,200 USD
2020-03-04 2020-03-02 PS Planned sale

Alenson Carman

Principal Accounting Officer

Officer
345 -65.2%
47.30
16,319 USD 		345 -65.2% 47.30 16,319 USD
2020-02-28 2020-02-26 PS Planned sale

Alenson Carman

Principal Accounting Officer

Officer
472 -72.0%
47.12
22,241 USD 		472 -72.0% 47.12 22,241 USD
2020-02-24 2020-02-20 PS Planned sale

Alenson Carman

Principal Accounting Officer

Officer
2,427 -93.0%
53.37
129,529 USD 		2,427 -93.0% 53.37 129,529 USD
2020-02-18 2020-02-13 PS Planned sale

Bowden Christopher

Chief Medical Officer

Officer
7,100 -81.1%
50.16
356,112 USD 		7,100 -81.1% 50.16 356,112 USD
2020-02-13 2020-02-11 PS Planned sale

Bowden Christopher

Chief Medical Officer

Officer
621 -27.3%
50.02
31,063 USD 		621 -27.3% 50.02 31,063 USD
2020-02-06 2020-02-04 PS Planned sale

Bowden Christopher

Chief Medical Officer
35,447 -95.6%
50.10
1,776,026 USD 		35,447 -95.6% 50.10 1,776,026 USD
2020-02-06 2020-02-04 PS Planned sale

Bowden Christopher

Chief Medical Officer
14,191 -89.6%
50.03
709,963 USD 		14,191 -89.6% 50.03 709,963 USD
2019-12-30 2019-12-26 PS Planned sale

Alenson Carman

Principal Accounting Officer

Officer
2,950 -94.1%
50.09
147,766 USD 		2,950 -94.1% 50.09 147,766 USD
2019-11-15 2019-11-13 B Purchase

FOUSE JACQUALYN A

Chief Executive Officer

Executive Director
40,322 +2880.1%
31.00
1,249,982 USD 		40,322 +2880.1% 31.00 1,249,982 USD
2019-11-15 2019-11-13 B Purchase

Schenkein David P

8,064 +9.0%
31.00
249,984 USD 		8,064 +9.0% 31.00 249,984 USD
2019-11-14 2019-11-12 B Purchase

CELGENE CORP /DE/

Large shareholder
403,225 +29.3%
31.00
12,499,975 USD 		403,225 +29.3% 31.00 12,499,975 USD